$17.74
0.23% yesterday
Nasdaq, May 20, 10:00 pm CET
ISIN
US14167L1035
Symbol
CDNA
Sector
Industry

CareDx, Inc. Stock price

$17.74
+0.80 4.72% 1M
-4.63 20.70% 6M
-3.67 17.14% YTD
+2.11 13.50% 1Y
-8.12 31.40% 3Y
-11.95 40.25% 5Y
+12.96 270.74% 10Y
Nasdaq, Closing price Tue, May 20 2025
+0.04 0.23%
ISIN
US14167L1035
Symbol
CDNA
Sector
Industry

Key metrics

Market capitalization $987.77m
Enterprise Value $787.13m
P/E (TTM) P/E ratio 15.40
EV/FCF (TTM) EV/FCF 39.06
EV/Sales (TTM) EV/Sales 2.27
P/S ratio (TTM) P/S ratio 2.85
P/B ratio (TTM) P/B ratio 2.59
Revenue growth (TTM) Revenue growth 25.92%
Revenue (TTM) Revenue $346.42m
EBIT (operating result TTM) EBIT $-30.86m
Free Cash Flow (TTM) Free Cash Flow $20.15m
Cash position $230.92m
EPS (TTM) EPS $1.15
P/E forward negative
P/S forward 2.66
EV/Sales forward 2.12
Short interest 11.26%
Show more

Is CareDx, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

CareDx, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a CareDx, Inc. forecast:

5x Buy
56%
4x Hold
44%

Analyst Opinions

9 Analysts have issued a CareDx, Inc. forecast:

Buy
56%
Hold
44%

Financial data from CareDx, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
346 346
26% 26%
100%
- Direct Costs 115 115
10% 10%
33%
232 232
36% 36%
67%
- Selling and Administrative Expenses 172 172
2% 2%
50%
- Research and Development Expense 72 72
5% 5%
21%
-12 -12
85% 85%
-3%
- Depreciation and Amortization 19 19
3% 3%
5%
EBIT (Operating Income) EBIT -31 -31
69% 69%
-9%
Net Profit 69 69
137% 137%
20%

In millions USD.

Don't miss a Thing! We will send you all news about CareDx, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

CareDx, Inc. Stock News

Neutral
Business Wire
7 days ago
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers — today announced the company will participate in the following investor conferences. Craig-Hallum 22nd Ann...
Neutral
Seeking Alpha
20 days ago
CareDx, Inc (NASDAQ:CDNA ) Q1 2025 Earnings Conference Call April 30, 2025 4:30 PM ET Company Participants Caroline Corner - Investor Relations John Hanna - President & Chief Executive Officer Robert Woodward - Chief Scientific Officer Abhishek Jain - Chief Financial Officer Keith Kennedy - Chief Operating Officer Conference Call Participants Mason Carrico - Stephens Brandon Couillard - Wells F...
Neutral
Business Wire
20 days ago
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) today reported financial results for the first quarter ended March 31, 2025. First Quarter Financial Highlights Reported first quarter revenue of $84.7 million, increased 18% year-over-year Testing services revenue of $61.9 million, increased 15% year-over-year, and testing services volume of approximately 47,100, increased 12% year...
More CareDx, Inc. News

Company Profile

CareDx, Inc. operates as a transplant diagnostics company,which discovers, develops, and commercializes diagnostic solutions. Its product includes AlloMap, AlloSure, and Laboratory products. The company was founded on December 21, 1998 and is headquartered in Brisbane, CA.

Head office United States
CEO John Hanna
Employees 650
Founded 1998
Website www.caredx.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today